Bevacizumab (Avastin) Into the Tumor Resection Cavity in Subjects With Glioblastoma Multiforme at First Recurrence

NCT01526837 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

1

Enrollment

OTHER

Sponsor class

Stopped Investigators decision

Conditions

Glioblastoma Multiforme

Interventions

DRUG: Avastin

Sponsor

Brain & Spine Surgeons of New York